Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033

Publish Date: Jul 2024

Report Code: TBR1580D

Publisher: TBRC (Publisher)

Download Report Overview

Single User License: $5000

Explore Our Services

Already a member? Login here.

Sample Report

Report Highlights

Including: 1) By Linker Type: Cleavable Linker; Non-Cleavable Linker
2) By Product: Kadcyla; Enhertu; Adcetris; Polivy; Trodelvy; Padcev
3) By Application: Hematopoietic Cancers; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor
4) By End User: Hospital; Clinics; Specialty Centers
Covering: F. Hoffmann-La Roche Ltd.; Daiichi Sankyo Company Limited; Seagen Inc.; Gilead Sciences Inc.; Genmab

Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global antibody drug conjugates market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:
Where is the largest and fastest-growing market for antibody drug conjugates? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The antibody drug conjugates market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider antibody drug conjugates market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by linker type, by product, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the antibody drug conjugates market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by linker type, by product, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for antibody drug conjugates providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Report Synopsis

Report Metrics	Details
Base year considered	2023
Forecast period considered	2023-2033
Units considered	$ Million
Segments covered	By Linker Type, By Product, By Application, By End User
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	China, Australia, India, Indonesia, Japan, South Korea, USA, Canada, Brazil, France, Germany, Italy, Spain, UK, Russia
Companies studied	F. Hoffmann-La Roche Ltd. Gilead Sciences Inc. Daiichi Sankyo Company Limited Seagen Inc. Genmab

Scope

Markets Covered:

By Linker Type: Cleavable Linker; Non-Cleavable Linker
By Product: Kadcyla; Enhertu; Adcetris; Polivy; Trodelvy; Padcev; Other Products
By Application: Hematopoietic Cancers; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Other Applications
By End User: Hospital; Clinics; Specialty Centers; Other End Users

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Daiichi Sankyo Company Limited; Seagen Inc.; Gilead Sciences Inc.; Genmab

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; antibody drug conjugates indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table 1 : Global Antibody Drug Conjugates Market, Historic, 2018 – 2023, $ Million
Table 2 : Global Antibody Drug Conjugates Market, Forecast, 2023 – 2028, 2033F, $ Million
Table 3 : Global Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 4 : Global Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 5 : Global Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 6 : Global Antibody Drug Conjugates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 7 : Global Antibody Drug Conjugates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 8 : Global Antibody Drug Conjugates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 9 : Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
Table 10 : Asia-Pacific Population, By Country, 2018-2028, Millions
Table 11 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 12 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 13 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 14 : China GDP Per Capita, 2018-2023, $
Table 15 : China Population, 2018-2028, Millions
Table 16 : China Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 17 : China Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 18 : China Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 19 : India Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 20 : India Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 21 : India Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 22 : Japan Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 23 : Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 24 : Japan Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 25 : Australia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 26 : Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 27 : Australia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 28 : Indonesia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 29 : Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 30 : Indonesia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 31 : South Korea Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 32 : South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 33 : South Korea Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 34 : Western Europe GDP Per Capita, By Country, 2018-2023, $
Table 35 : Western Europe Population, By Country, 2018-2028, Millions
Table 36 : Western Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 37 : Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 38 : Western Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 39 : UK Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 40 : UK Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 41 : UK Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 42 : Germany Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 43 : Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 44 : Germany Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 45 : France Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 46 : France Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 47 : France Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 48 : Italy Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 49 : Italy Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 50 : Italy Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 51 : Spain Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 52 : Spain Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 53 : Spain Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 54 : Eastern Europe GDP Per Capita, By Country, 2018-2023, $
Table 55 : Eastern Europe GDP Per Capita, By Country, 2018-2023, $
Table 56 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 57 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 58 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 59 : Russia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 60 : Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 61 : Russia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 62 : North America GDP Per Capita, By Country, 2018-2023, $
Table 63 : North America Population, By Country, 2018-2028, Millions
Table 64 : North America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 65 : North America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 66 : North America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 67 : USA GDP Per Capita, 2018-2023, $
Table 68 : USA Population, 2018-2028, Millions
Table 69 : USA Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 70 : USA Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 71 : USA Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 72 : Canada Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 73 : Canada Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 74 : Canada Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 75 : South America GDP Per Capita, By Country, 2017-2022, $
Table 76 : South America Population, By Country, 2017-2027, Millions
Table 77 : South America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 78 : South America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 79 : South America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 80 : Brazil Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 81 : Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 82 : Brazil Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 83 : Middle East GDP Per Capita, By Country, 2018-2023, $
Table 84 : Middle East Population, By Country, 2018-2028, Millions
Table 85 : Middle East Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 86 : Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 87 : Middle East Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 88 : Africa GDP Per Capita, By Country, 2018-2023, $
Table 89 : Africa Population, By Country, 2018-2028, Millions
Table 90 : Africa Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 91 : Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 92 : Africa Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 93 : Global Antibody Drug Conjugates Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Table 94 : F. Hoffmann-La Roche Ltd – Financial Overview, 2018 – 2022, $ Billion
Table 95 : Daiichi Sankyo Company Limited – Financial Overview, 2018 – 2022, $ Billion
Table 96 : Seagen Inc – Financial Overview, 2022, $Billion
Table 97 : Gilead Sciences Inc – Financial Overview, 2018 – 2022, $ Billion
Table 98 : Genmab A/S – Financial Overview, 2018 – 2022, $ Billion
Table 99 : Antibody Drug Conjugates Market, Competitive Benchmarking (In USD Millions)
Table 100 : Antibody Drug Conjugates Market, Competitive Dashboard
Table 101 : Global Antibody Drug Conjugates Market Size Gain ($ Million), 2023 – 2028, By Country
Table 102 : Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Linker Type, 2023 – 2028
Table 103 : Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Application, 2023 – 2028
Table 104 : Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By End User, 2023 – 2028
Table 105 : Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Product, 2023 – 2028
Table 106 : Antibody Drug Conjugates Market Data Sources

Figure 1 : Global Antibody Drug Conjugates Market Segmentation By Linked Type
Figure 2 : Global Antibody Drug Conjugates Market Segmentation By Product
Figure 3 : Global Antibody Drug Conjugates Market Segmentation By Product
Figure 4 : Global Antibody Drug Conjugates Market Segmentation By End User
Figure 5 : Global Antibody Drug Conjugates Market, Historic, 2018 – 2023, $ Million
Figure 6 : Global Antibody Drug Conjugates Market, Forecast, 2023 – 2028, 2033F, $ Million
Figure 7 : Global Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 8 : Global Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 9 : Global Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 10 : Global Antibody Drug Conjugates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 11 : Global Antibody Drug Conjugates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 12 : Global Antibody Drug Conjugates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 13 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 14 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 15 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 16 : China Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 17 : China Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 18 : China Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 19 : India Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 20 : India Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 21 : India Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 22 : Japan Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 23 : Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 24 : Japan Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 25 : Australia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 26 : Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 27 : Australia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 28 : Indonesia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 29 : Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 30 : Indonesia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 31 : South Korea Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 32 : South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 33 : South Korea Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 34 : Western Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 35 : Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 36 : Western Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 37 : UK Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 38 : UK Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 39 : UK Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 40 : Germany Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 41 : Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 42 : Germany Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 43 : France Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 44 : France Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 45 : France Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 46 : Italy Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 47 : Italy Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 48 : Italy Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 49 : Spain Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 50 : Spain Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 51 : Spain Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 52 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 53 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 54 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 55 : Russia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 56 : Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 57 : Russia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 58 : North America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 59 : North America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 60 : North America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 61 : USA Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 62 : USA Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 63 : USA Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 64 : Canada Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 65 : Canada Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 66 : Canada Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 67 : South America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 68 : South America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 69 : South America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 70 : Brazil Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 71 : Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 72 : Brazil Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 73 : Middle East Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 74 : Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 75 : Middle East Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 76 : Africa Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 77 : Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 78 : Africa Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 79 : Global Antibody Drug Conjugates Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Figure 80 : F. Hoffmann-La Roche Ltd – Financial Overview, 2018 – 2022, $ Billion
Figure 81 : Daiichi Sankyo Company Limited – Financial Overview, 2018 – 2022, $ Billion
Figure 82 : Gilead Sciences Inc – Financial Overview, 2018 – 2022, $ Billion
Figure 83 : Genmab A/S – Financial Overview, 2018 – 2022, $ Billion
Figure 84 : Geographic Regions Covered

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Antibody Drug Conjugates Global Market Report 2023

Published Date - Feb 2023
Report Code - TBR1580C

Including: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin
2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor
3) By Product: Adcertis; Kadcyla
4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology
5) By End User: Hospital; Clinics
Covering: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche Ltd.; ImmunomedicsInc.; Oxford BioTherapeutics

Antibody Drug Conjugates Global Market Report ...

Antibody Drug Conjugates Global Market Report 2022

Published Date - Mar 2022
Report Code - TBR1580B

Including: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Others
2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Others
3) By Product: Adcertis; Kadcyla; Others
4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Others
5) By End User: Hospital; Clinics; Others
Covering: Bayer AG; Concortis Biotherapeutics; F.Hoffman-La Roche Ltd.; Immunomedics ...

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

Published Date - Sep 2021
Report Code - TBR1580A

FAQ

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More

Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033

Report Highlights

Report Synopsis

Antibody Drug Conjugates Global Market Report 2023

Antibody Drug Conjugates Global Market Report 2022

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

Related Reports

Recent Reports

Top Trending Reports

Become A Member

Custom Consulting

Scorecard

Innovation Spotlight